Researchers discover a potential biomarker for AML relapse after stem cell … – Oncology Nurse Advisor
|
Researchers discover a potential biomarker for AML relapse after stem cell …
Oncology Nurse Advisor Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to a study recently published in Blood Cancer Journal (2015; doi:10.1038/bcj.2015.58). There is … |
